 |
Predictive medicine is in its early stages. We at Existence Genetics envision that the use of gene chips for genetic testing will be replaced within the next decade by full genome sequencing. Just as the mainframe computer that was once viable only for large business operations has evolved into the ubiquitous laptop PC, full genome sequencing will soon be accessible and affordable for everyone. Over time, every adult, child, newborn, and developing fetus will become a candidate for cost-effective full genome sequencing and analysis, and when that happens, predictive medicine will reach its full potential.
Existence Genetics has prepared for the genetic future by constructing our immense Predictive Medicine Database (PMD) and developing our Nexus technologies so that we can process genetic data acquired from any genetic testing platform, including the latest full genome sequencing technologies. The vast amount of genetic information produced by full genome sequencing will, however, end up as nothing more than a scientific paperweight unless it is analyzed, organized, and delivered in a useful and actionable form. Simply put, without a way to analyze all the data at a single time, the 6 billion bytes of information ascertained for each person from full genome sequencing will be of limited, if any, value to the individual and his or her health care providers. But with proper analysis, it becomes invaluable.
Our Nexus technologies were created with a specific goal: to enable clinical analysis of all full genome sequencing data, thereby providing the tools required to bring predictive medicine to the world. |
|
|
